TAIPEI, July 13, 2022 /PRNewswire/ — Health2Sync, Asia’s leading digital chronic disease management platform, announced today that it is signing a Memorandum of Understanding (MOU) with AstraZeneca Taiwan to provide its first digital solution for chronic kidney disease (CKD) patients in Taiwan. The partnership targets to reach an early diagnosis and optimize the quality of everyday chronic kidney disease care through the smart detection feature on the Health2Sync patient management platform, which is currently used by over 400 medical institutions worldwide. “With over nine years of experience in diabetes management, we are excited to see that our continuous efforts have...